Replies to post #208409 on Biotech Values

[ghmm]

CELG / Delinia / NKTR:

This is a similar approach to what NKTR-214 does. I don't know much about the Delinia program one possible (of perhaps many) differentiation is Nektar's is Pegylated and they are currently testing Q2W and Q3W dosing with Opdivo.

Here is the Atlas/Life Sciences Write up on the deal
https://lifescivc.com/2017/01/delinia-delivers-exciting-autoimmune-therapy-celgene/